Eupraxia Pharmaceuticals Inc. (T:EPRX*CA)

Business Focus: Biotechnology & Medical Research (NEC)

INK Ultra Money Free

Latest 10 SEDI filings (by transaction date) for EPRX*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET November 28th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 19/21 Nov 15/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 22,014 $1.81
Sep 27/21 Sep 21/21 Malone, Amanda Michelle Direct Ownership Common Shares 10 - Acquisition in the public market 3,700 $2.62
Sep 24/21 Sep 15/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 2,100 $2.16
USD
Sep 24/21 Sep 14/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 42,344 $2.16
USD
Aug 24/21 Aug 24/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 650 $3.03
Aug 24/21 Aug 23/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 100 $3.21
Aug 24/21 Aug 20/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 24,000 $3.02
Aug 12/21 Jun 8/21 Geyer, Paul Direct Ownership Common Shares 36 - Conversion or exchange 54,271  
Aug 12/21 Jun 8/21 Geyer, Paul Direct Ownership Convertible Loan 36 - Conversion or exchange -202,959  
Aug 6/21 Jun 8/21 Montalbano, John Direct Ownership Common Shares 36 - Conversion or exchange 52,945  
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for EPRX*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET November 28th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 19/21 Nov 15/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 22,014 $1.81
Oct 26/21 Mar 9/21 Wilmink, Michael Direct Ownership Common Shares 15 - Acquisition under a prospectus 3,050 $8.00
Oct 26/21 Mar 9/21 Wilmink, Michael Direct Ownership Warrants 15 - Acquisition under a prospectus 1,525  
Oct 26/21 Mar 3/21 Wilmink, Michael Direct Ownership Warrants 00 - Opening Balance-Initial SEDI Report    
Sep 27/21 Sep 21/21 Malone, Amanda Michelle Direct Ownership Common Shares 10 - Acquisition in the public market 3,700 $2.62
Sep 24/21 Sep 15/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 2,100 $2.16
USD
Sep 24/21 Sep 14/21 Wilmink, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 42,344 $2.16
USD
Aug 24/21 Aug 24/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 650 $3.03
Aug 24/21 Aug 23/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 100 $3.21
Aug 24/21 Aug 20/21 Helliwell, James Allen Direct Ownership Common Shares 10 - Acquisition in the public market 24,000 $3.02
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $EPRX.CA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Mind Medicine (MindMed) (E:MMED*CA)
IMV (T:IMV*CA)
Wesana Health Holdings (C:WESA*CA)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.